News
TipRanks on MSN17h
Pfizer’s New Phase 1 Study on PF-07832837: A Potential Game-Changer for Atopic Dermatitis
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1 clinical trial titled ‘A PHASE 1, ...
REGN banks on Dupixent and Eylea HD gains to offset Eylea's decline while oncology wins strengthen its diversified pipeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback